| Dennis Randall Beach, MD | |
|
2002 Hospital Way, Whitefish, MT 59937 | |
| (406) 862-6436 | |
| (406) 862-9978 |
| Full Name | Dennis Randall Beach |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 45 Years |
| Location | 2002 Hospital Way, Whitefish, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205931292 | NPI | - | NPPES |
| 0000021318 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MT8350 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Valley Hospital | Whitefish, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alpine Womens Center Pc | 1557433869 | 5 |
News Archive
The DIABIMMUNE project followed the development of 39 Finnish infants from birth to the age of three. Half of the children received 9-15 antibiotic treatments during the research period, and the other half did not receive any such treatments.
Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area.
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, blog editor Amie Newman interviews Trevor Mundel, president of the Global Health Program at the foundation, about the Global Burden of Disease Study 2010 published in the Lancet last week.
› Verified 8 days ago
| Entity Name | Alpine Womens Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841458601 PECOS PAC ID: 1557433869 Enrollment ID: O20080702000077 |
News Archive
The DIABIMMUNE project followed the development of 39 Finnish infants from birth to the age of three. Half of the children received 9-15 antibiotic treatments during the research period, and the other half did not receive any such treatments.
Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area.
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, blog editor Amie Newman interviews Trevor Mundel, president of the Global Health Program at the foundation, about the Global Burden of Disease Study 2010 published in the Lancet last week.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Randall Beach, MD 2002 Hospital Way, Whitefish, MT 59937 Ph: (406) 862-6436 | Dennis Randall Beach, MD 2002 Hospital Way, Whitefish, MT 59937 Ph: (406) 862-6436 |
News Archive
The DIABIMMUNE project followed the development of 39 Finnish infants from birth to the age of three. Half of the children received 9-15 antibiotic treatments during the research period, and the other half did not receive any such treatments.
Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area.
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial.
In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, blog editor Amie Newman interviews Trevor Mundel, president of the Global Health Program at the foundation, about the Global Burden of Disease Study 2010 published in the Lancet last week.
› Verified 8 days ago
Tessa Lynn Winterton, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2002 Hospital Way, Whitefish, MT 59937 Phone: 406-862-6436 | |
Dr. Kathleen M Lewison, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2002 Hospital Way, Whitefish, MT 59937 Phone: 406-862-6436 Fax: 406-862-9978 | |
Dr. Bradley Lawrence Kasavana, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2002 Hospital Way, Whitefish, MT 59937 Phone: 406-314-0010 Fax: 406-862-9978 | |
Mrs. Mirna D Bowden, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2002 Hospital Way, Whitefish, MT 59937 Phone: 406-862-6436 Fax: 406-862-9978 |